Elena Piskounova

Title: The Innovative Journey of Elena Piskounova

Introduction

Elena Piskounova, based in Dallas, TX, is a notable inventor with a significant focus on advancements in the field of microRNA biogenesis. With a total of three patents to her name, Elena has made substantial contributions to understanding the regulatory mechanisms involved in miRNA processing.

Latest Patents

Among her latest innovations is the patent titled "Lin28-mediated control of let-7 biogenesis." This groundbreaking work presents compositions and methods aimed at regulating microRNA-binding protein-mediated miRNA biogenesis, focusing specifically on the Lin28-mediated pathways. Notably, the patent addresses the role of Lin28A in recruiting 3' terminal uridylyl transferase (TUTase) for uridylation of pre-let-7. Furthermore, it outlines methods for screening agents that may inhibit TUTase-dependent Lin28A-mediated repression of let-7 miRNA, showcasing a sophisticated approach to manipulating gene expression.

Career Highlights

Elena has had a remarkable career, with significant tenure at prestigious institutions such as Dana-Farber Cancer Institute and Children's Medical Center Corporation. Her work at these institutions has facilitated her innovative research in the medical and scientific communities.

Collaborations

Throughout her career, Elena has had the opportunity to collaborate with esteemed professionals in her field, including Richard Gregory and Dimitrios Iliopoulos. These collaborations have likely enriched her research endeavors, contributing to her success as an inventor.

Conclusion

Elena Piskounova's inventive spirit and dedication to scientific research have resulted in valuable contributions to the field of microRNA biogenesis. As she continues to pursue innovation, her work holds promise for further advancements in genetic regulation and therapeutic applications.